252 related articles for article (PubMed ID: 21788545)
21. Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use.
Iyer V; Singh HS; Reiffel JA
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):237-47. PubMed ID: 22388002
[TBL] [Abstract][Full Text] [Related]
22. Treatment of dabigatran-associated bleeding: case report and review of the literature.
Harinstein LM; Morgan JW; Russo N
J Pharm Pract; 2013 Jun; 26(3):264-9. PubMed ID: 23160864
[TBL] [Abstract][Full Text] [Related]
23. Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.
Béné J; Saïd W; Rannou M; Deheul S; Coupe P; Gautier S
Ann Pharmacother; 2012 Jun; 46(6):e14. PubMed ID: 22669799
[TBL] [Abstract][Full Text] [Related]
24. Dabigatran for stroke prevention in atrial fibrillation.
Hohnloser SH; Diener HC
Hamostaseologie; 2012; 32(3):216-20. PubMed ID: 22739760
[TBL] [Abstract][Full Text] [Related]
25. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
Baetz BE; Spinler SA
Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996
[TBL] [Abstract][Full Text] [Related]
26. Dabigatran etexilate linked to fatal gastrointestinal hemorrhage.
Feinberg J; Grabowitz L; Rotman-Pikielny P; Berla M; Levy Y
Isr Med Assoc J; 2014 Jun; 16(6):388-9. PubMed ID: 25059005
[No Abstract] [Full Text] [Related]
27. [Dabigatran, a new oral anticoagulant].
Uchiyama S
Brain Nerve; 2011 Apr; 63(4):411-5. PubMed ID: 21441645
[TBL] [Abstract][Full Text] [Related]
28. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
van Ryn J; Stangier J; Haertter S; Liesenfeld KH; Wienen W; Feuring M; Clemens A
Thromb Haemost; 2010 Jun; 103(6):1116-27. PubMed ID: 20352166
[TBL] [Abstract][Full Text] [Related]
29. Impaired renal function and bleeding in elderly treated with dabigatran.
Berthelot E; Lavenu-Bombled C; Orostegui-Giron L; Desconclois C; Assayag P
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):618-20. PubMed ID: 24509332
[TBL] [Abstract][Full Text] [Related]
30. The pharmacology and therapeutic use of dabigatran etexilate.
Sarah S
J Clin Pharmacol; 2013 Jan; 53(1):1-13. PubMed ID: 23400738
[TBL] [Abstract][Full Text] [Related]
31. NICE backs new oral anticoagulant for stroke prevention.
Wise J
BMJ; 2012 Mar; 344():e2111. PubMed ID: 22427274
[No Abstract] [Full Text] [Related]
32. Namibia becomes first country in Africa to launch dabigatran etexilate for atrial fibrillation.
Wagenaar P
Cardiovasc J Afr; 2011; 22(5):283. PubMed ID: 21983957
[No Abstract] [Full Text] [Related]
33. Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
Garza R; Huo MH
Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):423-7. PubMed ID: 22458575
[TBL] [Abstract][Full Text] [Related]
34. Rash associated with dabigatran etexilate.
To K; Reynolds C; Spinler SA
Pharmacotherapy; 2013 Mar; 33(3):e23-7. PubMed ID: 23400964
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal disorders and dabigatran.
Hoffman A; Galle PR
Scand J Gastroenterol; 2013 Jan; 48(1):9-16. PubMed ID: 22958146
[TBL] [Abstract][Full Text] [Related]
36. [Dabigatran: a new therapeutic alternative in the prevention of stroke].
Gállego J; Gil Alzueta MC
Neurologia; 2012 Mar; 27 Suppl 1():39-45. PubMed ID: 22682209
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
McKellar SH; Abel S; Camp CL; Suri RM; Ereth MH; Schaff HV
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1410-6. PubMed ID: 21429525
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.
Stangier J; Clemens A
Clin Appl Thromb Hemost; 2009; 15 Suppl 1():9S-16S. PubMed ID: 19696042
[TBL] [Abstract][Full Text] [Related]
39. Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile.
Clemens A; van Ryn J; Sennewald R; Yamamura N; Stangier J; Feuring M; Härtter S
Eur J Clin Pharmacol; 2012 May; 68(5):607-16. PubMed ID: 22252796
[TBL] [Abstract][Full Text] [Related]
40. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
Wychowski MK; Kouides PA
Ann Pharmacother; 2012 Apr; 46(4):e10. PubMed ID: 22496474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
